by Lior Shkedi | Aug 28, 2024 | Uncategorized
A Deep Dive into CGRP Utilization Management THE INTRODUCTION Migraines are all too familiar for many, with 18% of women and 6% of men in the U.S. experiencing these intense headaches each year. Thought to be a neurovascular pain syndrome, migraines involve...
by Lior Shkedi | Jul 23, 2024 | Uncategorized
A BREATH OF FRESH AIR Asthma affects over 260 million people worldwide. This chronic respiratory condition doesn’t discriminate, touching lives across all ages and demographics. It’s the most common chronic condition among children, but the good news is, with the...
by Lior Shkedi | Jun 28, 2024 | Uncategorized
SUFFERING FROM ALLERGIES? DISCOVER NEWER DRUG OPTIONS THAT ADDRESS MORE THAN JUST SYMPTOMS Spring arrives in an explosion of tree buds, dandelions, and lush green grass. You open your windows to savor the scent of freshly dug earth and the cheerful chirping of robins,...
by Lior Shkedi | Jun 12, 2024 | Uncategorized
CERPASSRX CONTINUES TO DELIVER VALUE BY ADDING SIMLANDI TO ITS FORMULARY AT PARITY WITH HUMIRA CerpassRx is excited to announce a significant update to our formulary with the addition of Simlandi, a citrate-free, high-concentration, interchangeable biosimilar to...
by Lior Shkedi | May 30, 2024 | Uncategorized
UNDERSTANDING MULTIPLE SCLEROSIS (MS) Multiple Sclerosis (MS) is a progressive, disabling disease that primarily affects the central nervous system, which includes the brain, spinal cord, and optic nerves. Despite significant research, the exact cause of MS remains...
